Precipio Inc (NASDAQ:PRPO) achieved its goal of reaching break-even by the end of 2024, with positive adjusted EBITDA and positive cash flow. The company reported a revenue growth of nearly 26% in ...

Q4 2024 Earnings Call Transcript March 31, 2025 Operator: Welcome to the Precipio Q4 and Year-End 2024 Shareholder Update Conference Call. All participants will be in listen-only mode. [Operator ...

Precipio Inc. reported a strong performance in Q4 2024, with nearly 26% revenue growth compared to the previous year. The company also achieved positive adjusted EBITDA and cash flow. According to ...

Welcome to the Precipio Q4 and Year-End 2024 Shareholder Update Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note that the conference is being ...

Precipio Inc. reported a strong performance in Q4 2024, with nearly 26% revenue growth compared to the previous year. The company also achieved positive adjusted EBITDA and cash flow. According to ...

Precipio Inc (PRPO) reports positive cash flow and revenue growth, while addressing challenges in its product division and enhancing market visibility for 2025. Precipio ( NASDAQ:PRPO ) Full Year ...

NEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4 and year end 2024 corporate update call on March ...